Results 201 to 210 of about 70,465,383 (301)
Laser-Induced Photothermal Conversion to Hemispherical MoS<sub>2</sub> Enabling Non-Contact Self-Powering Image Sensor. [PDF]
Kim CJ +18 more
europepmc +1 more source
CMOS Image Sensor Dreams of Intelligent Sensors. Amplified Image Sensors.
Ohtake, Hiroshi, Watanabe, Toshihide
openaire +2 more sources
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic +10 more
wiley +1 more source
Conformal Retinal Image Sensor Based on Electrochemically Exfoliated MoS<sub>2</sub> Nanosheets. [PDF]
Li T +6 more
europepmc +1 more source
The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad +2 more
wiley +1 more source
CMOS-Based Implantable Multi-Ion Image Sensor for Mg<sup>2+</sup> Measurement in the Brain. [PDF]
Nakamura Y +7 more
europepmc +1 more source
Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen +19 more
wiley +1 more source
Study on 3D Effects on Small Time Delay Integration Image Sensor Pixels. [PDF]
Guo S +5 more
europepmc +1 more source
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source

